Literature DB >> 16051509

Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis.

Tito Mendoza1, Tracy Mayne, Dale Rublee, Charles Cleeland.   

Abstract

The Brief Pain Inventory short form (BPI-sf) is a validated, widely used, self-administered questionnaire developed to assess the severity of pain and the impact of pain on daily functions. A modified version was used daily in randomised control trials of patients with arthritis undergoing treatment with cyclooxygenase-2 specific inhibitors and non-steroidal anti-inflammatory drugs. Results indicate that the modified BPI-sf, much like the original scale, was internally reliable, consistent over time, and had good construct, as well as convergent and predictive validity in assessment of patients suffering from conditions of chronic pain. Each scale and individual pain intensity item refers to changes in osteoarthritis pain associated with medication use. The modified BPI-sf, like the parent scale, is a valid and reliable tool for situations in which pain is assessed daily and minimises the burden placed on patients to record information necessary for scientific investigations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051509     DOI: 10.1016/j.ejpain.2005.06.002

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  114 in total

1.  [External validity of pain-linked functional interference: are we measuring what we want to measure?].

Authors:  J Rothaug; T Weiss; W Meissner
Journal:  Schmerz       Date:  2012-08       Impact factor: 1.107

2.  A community pain service solution-focused pain management programme: delivery and preliminary outcome data.

Authors:  Rebecca Simm; Joanne Iddon; Chris Barker
Journal:  Br J Pain       Date:  2014-02

3.  Chronic pain severity in opioid-dependent patients.

Authors:  Jennifer S Potter; Sara J Shiffman; Roger D Weiss
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

4.  Telephone interventions for co-morbid insomnia and osteoarthritis pain: The OsteoArthritis and Therapy for Sleep (OATS) randomized trial design.

Authors:  Susan M McCurry; Michael Von Korff; Charles M Morin; Amy Cunningham; Kenneth C Pike; Manu Thakral; Robert Wellman; Kai Yeung; Weiwei Zhu; Michael V Vitiello
Journal:  Contemp Clin Trials       Date:  2019-10-13       Impact factor: 2.226

5.  Sternal cables are not superior to traditional sternal wiring for preventing deep sternal wound infection.

Authors:  Ben Dunne; Mark Murphy; Rohen Skiba; Xiao Wang; Kwok Ho; Robert Larbalestier; Christopher Merry
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-02-23

6.  PTSD as a Mediator in the Relationship Between Post-Concussive Symptoms and Pain Among OEF/OIF/OND Veterans.

Authors:  Kimberly M Avallone; Erin R Smith; Sean Ma; Sean Gargan; Katherine E Porter; Caitlin C Authier; Brian Martis; Israel Liberzon; Sheila A M Rauch
Journal:  Mil Med       Date:  2019-01-01       Impact factor: 1.437

7.  The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations.

Authors:  Thomas M Atkinson; Tito R Mendoza; Laura Sit; Steven Passik; Howard I Scher; Charles Cleeland; Ethan Basch
Journal:  Pain Med       Date:  2010-01-15       Impact factor: 3.750

8.  Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option.

Authors:  Raja Shaikh; Ahmad I Alomari; Cindy L Kerr; Patricia Miller; Samantha A Spencer
Journal:  Pediatr Radiol       Date:  2016-02-22

Review 9.  Percutaneous Image-Guided Cryoablation in Vascular Anomalies.

Authors:  Raja Shaikh
Journal:  Semin Intervent Radiol       Date:  2017-09-11       Impact factor: 1.513

Review 10.  Acupuncture for treating aromatase inhibitor-related arthralgia in breast cancer: a systematic review and meta-analysis.

Authors:  Tsai-Ju Chien; Chia-Yu Liu; Yi-Fang Chang; Ching-Ju Fang; Chung-Hua Hsu
Journal:  J Altern Complement Med       Date:  2015-04-27       Impact factor: 2.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.